Sentinel lymph node identification in early stage ovarian cancer: is it still possible after prior tumor resection?
Pim Laven, Roy Kruitwagen, Petra Zusterzeel...
https://pubmed.ncbi.nlm.nih.gov/34645514/Actively Recruiting
Led by Faculty of Medicine of Tunis · Updated on 2026-09-10
30
Participants Needed
1
Research Sites
8 weeks
Total Duration
This research aims to evaluate the use of sentinel lymph node biopsy with patent blue dye in patients with early-stage ovarian cancer FIGO stage I or II. The standard treatment involves complete surgery including removal of the uterus, ovaries, and lymph nodes, but this extensive surgery carries risks such as blood loss and long recovery. The study investigates if using the sentinel lymph node biopsy technique can reduce these risks by identifying the first lymph node that cancer may spread to, potentially minimizing the extent of lymph node removal. During surgery, the patent blue dye will be injected into specific ligaments near the ovarian tumor. After waiting 15 minutes, surgeons will identify and remove the sentinel lymph nodes from pelvic and para-aortic areas for pathological analysis. Then, the standard complete surgery including full lymphadenectomy will be performed. The study compares the results of sentinel lymph node biopsy with those of the complete lymphadenectomy to assess feasibility and accuracy. Participants will undergo preoperative imaging and biomarker tests, followed by the surgical procedure where sentinel lymph node mapping and complete lymphadenectomy take place. Data collected include patient demographics, surgical details, tumor characteristics, and postoperative outcomes such as complications and hospital stay. Researchers will measure technical feasibility, diagnostic accuracy, and anatomical distribution of sentinel nodes, monitoring pathology results within four weeks post-surgery. The study is observational and aims to improve surgical care while minimizing morbidity.
CONDITIONS
Patent Blue SLN in Early Ovarian Cancer Prospective Study (FIGO I-II) Evaluating Patent Blue SLN Mapping. Injection Into IP/UO Ligaments in Situ. Goals: Assess Feasibility and Accuracy vs Standard Lymphadenectomy to Minimize Surgical Morbidity
M
Mohammed Amine Hannachi, Assistant professor
K
Khaled Neji, Professor
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Faculty of Medicine of Tunis
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single surgical session
Participants undergo surgery where patent blue dye is injected to locate sentinel lymph nodes. These nodes are removed and analyzed, followed by complete lymphadenectomy and other standard surgical steps.
Surgical and immediate postoperative care visits
Duration - Up to 4 weeks after surgery
Participants are monitored for recovery, complications, and receive postoperative care. Pathology results from lymph node analysis are reviewed within four weeks after surgery.
Follow-up visits as needed
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Pim Laven, Roy Kruitwagen, Petra Zusterzeel...
https://pubmed.ncbi.nlm.nih.gov/34645514/Nuria Agusti, Pilar Paredes, Sergi Vidal-Sicart...
https://pubmed.ncbi.nlm.nih.gov/35470254/N-T Van, H-T Nguyen-Xuan, M Koual...
https://pubmed.ncbi.nlm.nih.gov/34562642/Georgia Zachou, Gabriella Yongue, Dhivya Chandrasekaran
https://pubmed.ncbi.nlm.nih.gov/37892029/Núria Agustí, Sergi Vidal-Sicart, Pilar Paredes...
https://pubmed.ncbi.nlm.nih.gov/37980769/Jieyu Wang, Shouzhen Chen, Fangfang Zhong...
https://pubmed.ncbi.nlm.nih.gov/36974675/Camilla Nero, Nicolò Bizzarri, Stefano Di Berardino...
https://pubmed.ncbi.nlm.nih.gov/38006759/Nuria Agusti, David Viveros-Carreño, Carlos Grillo-Ardila...
https://pubmed.ncbi.nlm.nih.gov/37487662/Iria Rey, Víctor Lago, Marta Arnáez...
https://pubmed.ncbi.nlm.nih.gov/39414311/Menghan Zhu, Jun Li, Lijuan Lu...
https://pubmed.ncbi.nlm.nih.gov/39206992/Faculty of Medicine of Tunis
Lead Sponsor